Abstract
Dried blood spot (DBS) samples can be used for the detection of severe acute respiratory syndrome coronavirus 2 spike antibodies. DBS sampling is comparable to matched serum samples with a relative 98.1% sensitivity and 100% specificity. Thus, DBS sampling offers an alternative for population-wide serologic testing in the coronavirus pandemic.
Keywords:
COVID-19; DBS; SARS-CoV-2; antibody; coronavirus disease; dried blood spot; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Viral / immunology
-
COVID-19 / diagnosis*
-
COVID-19 Serological Testing / methods
-
Case-Control Studies
-
Dried Blood Spot Testing / economics
-
Dried Blood Spot Testing / methods*
-
Humans
-
Predictive Value of Tests
-
SARS-CoV-2 / immunology
-
Spike Glycoprotein, Coronavirus / immunology
-
Spike Glycoprotein, Coronavirus / isolation & purification
Substances
-
Antibodies, Viral
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2